Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Retained Earnings (2016 - 2025)

Tandem Diabetes Care's Retained Earnings history spans 13 years, with the latest figure at $5.6 million for Q4 2025.

  • For Q4 2025, Retained Earnings rose 387.26% year-over-year to $5.6 million; the TTM value through Dec 2025 reached $5.6 million, up 387.26%, while the annual FY2025 figure was $5.6 million, 387.26% up from the prior year.
  • Retained Earnings reached $5.6 million in Q4 2025 per TNDM's latest filing, up from $5.2 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $5.6 million in Q4 2025 to a low of -$1.0 billion in Q3 2024.
  • Average Retained Earnings over 5 years is -$327.8 million, with a median of -$1.9 million recorded in 2022.
  • Peak YoY movement for Retained Earnings: crashed 5095357.14% in 2022, then surged 398.88% in 2025.
  • A 5-year view of Retained Earnings shows it stood at -$616000.0 in 2021, then crashed by 194.97% to -$1.8 million in 2022, then plummeted by 52283.05% to -$951.8 million in 2023, then surged by 99.8% to -$1.9 million in 2024, then soared by 387.26% to $5.6 million in 2025.
  • Per Business Quant, the three most recent readings for TNDM's Retained Earnings are $5.6 million (Q4 2025), $5.2 million (Q3 2025), and $3.7 million (Q2 2025).